Z. Li, “Statins in Hepatitis B or C Patients Is Associated With Reduced Hepatocellular Carcinoma Risk: A Systematic Review and Meta-Analysis”, Turkish Journal of Gastroenterology, vol. 33, no. 2, pp. 136–144, Jan. 2022.